A groundbreaking brain imaging study shows why the gold-standard Parkinson’s drug doesn’t work for everyone—and how doctors ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...